MyAverix Finance
F · Healthcare
ASTELLAS PHARMA UNSP.ADR (YPHA)
Drug Manufacturers - General
ASTELLAS PHARMA UNSP.ADR (YPHA) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-03-31, reported market cap is $24.00B, P/E ratio is 35.26, net margin is 15.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for YPHA
ASTELLAS PHARMA UNSP.ADR (YPHA) — FAQ
What is ASTELLAS PHARMA UNSP.ADR's market cap?
ASTELLAS PHARMA UNSP.ADR (YPHA) has a reported market cap of $24.00B (data as of 2026-03-31).
What is YPHA's P/E ratio?
The price-to-earnings (P/E) ratio for ASTELLAS PHARMA UNSP.ADR (YPHA) is 35.26 (data as of 2026-03-31).
Does ASTELLAS PHARMA UNSP.ADR pay a dividend?
Dividend yield is not available in the current snapshot for ASTELLAS PHARMA UNSP.ADR (YPHA). Check the MyAverix Finance app for the latest dividend data.
What sector is ASTELLAS PHARMA UNSP.ADR in?
ASTELLAS PHARMA UNSP.ADR (YPHA) is classified in the Healthcare sector (Drug Manufacturers - General industry).
What exchange is YPHA listed on?
YPHA is listed on F.
What is ASTELLAS PHARMA UNSP.ADR's net margin?
ASTELLAS PHARMA UNSP.ADR (YPHA) reports a net margin of 15.7% (data as of 2026-03-31).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.